Sildenafil Citrate NDC 75834-240

Product information

Brand name (proprietary)

Sildenafil Citrate

Generic name (nonproprietary)

sildenafil citrate

Active ingredients

Sildenafil citrate — 50 mg/1

Dosage form

Tablet

Route

Oral

Labeler

NIVAGEN PHARMACEUTICALS, INC.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 209302

Marketing start

Sep 4, 2020

Listing expires

Dec 31, 2027

Other FDA classes

Phosphodiesterase 5 Inhibitors (Mechanism)

Identifiers

Product ID 75834-240_506bb4eb-697e-9d05-e063-6294a90a8f2cSPL ID 506bb4eb-697e-9d05-e063-6294a90a8f2cSPL set ID 5ac95dd0-57e4-495c-bf8d-b2e5bbe33e20RxCUI 312950, 314228, 314229UNII BW9B0ZE037UPC 0375834272900, 0375834241012, 0375834241302, 0375834240015, 0375834272009, 0375834240008, 0375834272306, 0375834240305, 0375834241005, 0375834240053

Pharmacologic class

Phosphodiesterase 5 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475834024000 followed by a unit qualifier and the quantity Copy

Package 75834-0240-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 209302

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.